angina & no obstructive coronary artery disease (ANOCA)

^[1]^[2]

Introduction

6 weeks of treatment with diltiazem did not improve coronary vasomotor dysfunction

↑ Jansen TPJ, Konst RE, Elias-Smale SE et al Assessing Microvascular Dysfunction in Angina With Unobstructed Coronary Arteries: JACC Review Topic of the Week. J Am Coll Cardiol. 2021 Oct 5;78(14):1471-1479 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34593129
↑ Busko M Diltiazem Fails to Improve Vasomotor Dysfunction, Angina in ANOCA: EDIT-CMD Medscape. April 3, 2022 https://www.medscape.com/viewarticle/971489
Jansen TPJ, Konst RE, de Vos A Efficacy of Diltiazem to improve coronary vasomotor dysfunction in angina and nonobstructive coronary arteries (ANOCA): Results of the EDIT-CMD randomized clinical trial. JACC: Cardiovascular Imaging 2022 Feb 22 Not indexed in PubMed https://www.jacc.org/doi/pdf/10.1016/j.jcmg.2022.03.012